ctrl K

Price Alert

China SXT Pharmaceuticals... (SXTC)

NASDAQ: SXTC · Real-Time Price · USD

1.65

0.07 (4.43%)

At close: Aug 15, 2025, 10:02 AM

China SXT Pharmaceuticals Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	1.74M	1.93M	1.97M	2.6M	4.78M
Cost of Revenue	1.37M	1.37M	1.55M	1.35M	1.94M
Gross Profit	367.43K	553.97K	426.27K	1.25M	2.84M
Operating Income	-2.68M	-2.52M	-5.61M	-5.19M	-2.2M
Interest Income	n/a	n/a	n/a	n/a	1.11M
Pretax Income	-3.3M	-3.1M	-5.93M	-5.41M	-2.94M
Net Income	-3.3M	-3.1M	-5.93M	-5.74M	-2.75M
Selling & General & Admin	3.05M	3.07M	6.03M	6.44M	5.04M
Research & Development	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	3.05M	3.07M	6.03M	6.44M	5.04M
Interest Expense	648.22K	544.28K	476.78K	36.7K	1.62M
Selling & Marketing Expenses	289.86K	433.57K	387.45K	924.54K	1.59M
Cost & Expenses	4.42M	4.44M	7.58M	7.79M	6.97M
Income Tax Expense	n/a	n/a	n/a	328.15K	-192.68K
Shares Outstanding (Basic)	403.92K	867.42K	266.97K	41.59K	28.78K
Shares Outstanding (Diluted)	403.92K	867.42K	266.97K	41.59K	28.78K
EPS (Basic)	-8.18	-3.57	-22.23	-137.92	-95.48
EPS (Diluted)	-8.18	-3.57	-22.23	-137.92	-95.48
EBITDA	-2.57M	-2.35M	-5.21M	-5.05M	-1.85M
EBIT	-2.66M	-2.55M	-5.46M	-5.37M	-2.2M
Depreciation & Amortization	82.3K	203.25K	250.16K	320.01K	345.41K